These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3318250)

  • 1. [Use of direct solid-phase immunoenzyme analysis for assessing the immunological activity of a vaccine against tick-borne encephalitis].
    Timofeev AV; El'bert LB; Terletskaia EN; Mal'dov DG; Karavanov AS
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Sep; (9):89-93. PubMed ID: 3318250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparison of the protective properties of preparations of the virion and nonvirion ("soluble") antigens of the tick-borne encephalitis virus].
    Liapustin VN; Pivanova GP; Karavanov AS; Lashkevich VA
    Vopr Virusol; 1991; 36(6):498-500. PubMed ID: 1785186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Isolation of split and whole-virion tick-borne encephalitis vaccines in an experiment and the characteristics of their immunogenic and antigenic properties].
    Osipova EG; Solianik RG; Fedorov IuV; Tymchishin PN
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Aug; (8):50-3. PubMed ID: 3687295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reactogenicity and antigenic activity of a chromatographic cultured purified and concentrated inactivated dried vaccine against tick-borne encephalitis].
    Popov OV; Sumarokov AA; Shkol'nik RIa; El'bert LB; Vorob'eva MS
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Jun; (6):34-9. PubMed ID: 3898672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of inbred mice for assessing the neurovirulence of strains of the tick-borne encephalitis virus complex and the immunogenicity of a concentrated tick-borne encephalitis vaccine].
    Kan GA; Borsuk EA; Vorob'eva MS
    Vopr Virusol; 1982; 27(4):461-4. PubMed ID: 7135927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reactogenicity and immunological effectiveness of a concentrated, purified vaccine against tick-borne encephalitis].
    Vorob'eva MS; El'bert LB; Grachev VP; Lelikov VL; Pervikov IuV
    Vopr Virusol; 1983; 28(5):622-6. PubMed ID: 6659477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Concentrated purified vaccine against tick-borne encephalitis. An immunological evaluation in experiments on mice].
    Khotlubeĭ LI; Pervikov IuV; Krutianskaia GL; Vil'ner LM; Semenov BF
    Vopr Virusol; 1982; 27(3):316-20. PubMed ID: 7123913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The relationship of the antigenic characteristics of the tick-borne encephalitis virus to the level of the protective activity of inactivated cultured vaccines].
    Vorob'eva MS; Rasshchepkina MN
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (11-12):35-7. PubMed ID: 1301660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The protective activity of preparations made from the tick-borne encephalitis virus grown using different cell cultures].
    El'bert LB; Vorovich MF; Terletskaia EN; Lisitsina EA; Atanadze SN; Sidorovich IG; Khozinskiĭ VV; Tugizov ShM; Kushch AA; Khapchaev IuKh
    Zh Mikrobiol Epidemiol Immunobiol; 1992 Jan; (1):25-8. PubMed ID: 1414102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic relationships between an isolate of the Western Subtype of tick-borne encephalitis virus and an inactivated vaccine derived from it.
    Lee JM; Stephenson JR
    Vaccine; 1985 Sep; 3(3):292-6. PubMed ID: 2998112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunological indices of human vaccination against tick-borne encephalitis using inactivated preparations with a varying concentration of the viral antigen].
    El'bert LB; Pervikov IuV; Krutianskaia GL; Krasil'nikov IV; Grachev VP
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jun; (6):89-92. PubMed ID: 7293574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cleaved vaccine against tick-borne encephalitis].
    Osipova EG; Solianik RG; Fedorov IuV
    Tr Inst Im Pastera; 1989; 65():155-9. PubMed ID: 2629184
    [No Abstract]   [Full Text] [Related]  

  • 14. [Donor immunization with an inactivated concentrated purified vaccine against tick-borne encephalitis to obtain immune blood preparations].
    El'bert LB; Pervikov IuV; Grachev VP; Rusanov VM; Krokhina MA
    Vopr Virusol; 1984; 29(1):56-9. PubMed ID: 6608828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparison of the immune response induced by DNA or by an inactivated vaccine against tick-borne encephalitis].
    Morozova OV; Popova RV; Maksimova TG; Mitrofanova EE; Bakhvalova VN
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (2):54-7. PubMed ID: 10808575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
    Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
    Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A cultured concentrated inactivated vaccine against tick-borne encephalitis studied during the immunization of children and adolescents].
    Pavlova LI; Gorbunov MA; Vorob'eva MS; Karavanov AS; Grachev VP; Ladyshenskaia IP; Rasshchepkina MN; Mel'nikova LN; Lebedeva TM; Mel'nikov NA; Gusmanova AG; Deviatkov MIu; Rozanova EV; Mukachev MA
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (6):50-3. PubMed ID: 10876850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A live vaccine against tick-borne encephalitis: the principles of selecting the vaccinal strains].
    Kamalov II; Sokolova ED; Il'enko VI; Rozhkova LV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (3):70-6. PubMed ID: 8067096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study of inactivated cultured vaccines against tick-borne encephalitis manufactured in Russia and in Austria by the "Immuno" firm].
    Vorob'eva MS; Rasshchepkina MN; Ladyzhenskaia IP; Gorbunov MA; Pavlova LI; Bektimirov TA
    Vopr Virusol; 1996; 41(5):221-4. PubMed ID: 8967069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical investigations of the safety, immunogenicity and efficacy of a purified, inactivated tick-borne encephalitis vaccine.
    Klockmann U; Bock HL; Franke V; Hein B; Reiner G; Hilfenhaus J
    J Biol Stand; 1989 Oct; 17(4):331-42. PubMed ID: 2613707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.